News Lilly, PTC snap up bankrupt Sangamo's main assets Just a few weeks after filing for bankruptcy protection, Sangamo has found buyers for some of its key assets, raising up to $263.5m.
News Lilly inflates US facility investment spending by $4.5bn Having already committed last year to capital investments of $27 billion in the US to ward off the threat of tariffs, Eli Lilly has upped the ante.
News Mirai Bio launches with plan to help genetic med developers Flagship Pioneering's latest biotech launch, Mirai Bio, aims to help genetic medicine developers find the best way to get their drugs to patients.
News Lilly adds to genetic meds push with Genetic Leap alliance In its second R&D alliance this week, Eli Lilly has formed a partnership with Genetic Leap, a startup that focuses on applying artificial intelligence to the discovery of RNA-targeted t
News Aera Tx launches with $193m in financing for genetic meds Aera Therapeutics announces launch with $193m financing from leading life sciences investors.
News MFN affecting Swiss medicines access, says Interpharma Pharma groups have held back from submitting around a third of their new medicines for reimbursement in Switzerland, impeding patient access.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
